IRIS
FRANZONE, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.455
NA - Nord America 3.984
EU - Europa 3.348
SA - Sud America 614
Continente sconosciuto - Info sul continente non disponibili 234
AF - Africa 159
OC - Oceania 11
Totale 13.805
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.819
SG - Singapore 2.262
RU - Federazione Russa 1.596
CN - Cina 1.113
VN - Vietnam 1.031
IT - Italia 687
BR - Brasile 471
HK - Hong Kong 404
FR - Francia 223
NL - Olanda 195
DE - Germania 191
BD - Bangladesh 155
JP - Giappone 117
GB - Regno Unito 101
FI - Finlandia 89
IN - India 79
CA - Canada 78
KR - Corea 60
IE - Irlanda 58
AR - Argentina 52
CI - Costa d'Avorio 50
MX - Messico 44
ZA - Sudafrica 32
AT - Austria 30
PH - Filippine 28
EC - Ecuador 26
PL - Polonia 26
TH - Thailandia 26
ID - Indonesia 24
IQ - Iraq 23
UA - Ucraina 23
ES - Italia 22
SE - Svezia 19
CZ - Repubblica Ceca 18
CH - Svizzera 16
PK - Pakistan 16
CL - Cile 14
KE - Kenya 14
MA - Marocco 14
TR - Turchia 12
JO - Giordania 11
TW - Taiwan 11
UZ - Uzbekistan 11
PY - Paraguay 10
VE - Venezuela 10
AZ - Azerbaigian 9
BE - Belgio 9
CO - Colombia 9
EG - Egitto 9
LT - Lituania 9
NP - Nepal 8
PE - Perù 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
SA - Arabia Saudita 7
AU - Australia 6
BO - Bolivia 6
PS - Palestinian Territory 6
UY - Uruguay 6
HN - Honduras 5
IR - Iran 5
JM - Giamaica 5
MY - Malesia 5
PT - Portogallo 5
SN - Senegal 5
AL - Albania 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
NG - Nigeria 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PA - Panama 4
RS - Serbia 4
BG - Bulgaria 3
DZ - Algeria 3
EE - Estonia 3
IL - Israele 3
MK - Macedonia 3
AO - Angola 2
BF - Burkina Faso 2
BS - Bahamas 2
BY - Bielorussia 2
ET - Etiopia 2
KW - Kuwait 2
MD - Moldavia 2
ME - Montenegro 2
MG - Madagascar 2
RO - Romania 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
Totale 13.545
Salva come PNG Salva come JPEG
Città #
Singapore 1.094
San Jose 775
Ashburn 439
Hong Kong 385
Moscow 370
Ho Chi Minh City 308
Beijing 277
Hefei 244
Hanoi 230
Chandler 186
Naples 177
Amsterdam 167
Santa Clara 135
Lauterbourg 125
Los Angeles 121
The Dalles 118
Millbury 117
Tokyo 99
Nanjing 86
Princeton 81
New York 72
Munich 68
Redondo Beach 60
Napoli 57
Boston 54
Buffalo 53
Des Moines 52
São Paulo 50
Seoul 46
Dallas 43
Frankfurt am Main 41
Haiphong 41
Da Nang 35
Orem 33
Council Bluffs 32
Wilmington 30
Milan 29
Rome 28
Denver 26
Nuremberg 26
Nanchang 25
Ottawa 24
Chicago 22
Phoenix 21
Helsinki 20
Atlanta 19
Warsaw 19
Mexico City 18
Hebei 17
Afragola 16
Lawrence 16
London 16
Brooklyn 15
Chennai 15
Montreal 15
Rio de Janeiro 15
Seattle 15
Shenyang 15
Stockholm 15
Poplar 14
San Francisco 14
Tianjin 14
Toronto 14
Turku 14
Biên Hòa 13
Changsha 13
Dong Ket 13
Guayaquil 13
Houston 13
Vienna 13
Washington 13
Brasília 12
Brno 12
Can Tho 12
Hải Dương 12
Johannesburg 12
Nairobi 12
Bern 11
Jacksonville 11
Kunming 11
Lappeenranta 11
Shanghai 11
Tashkent 11
Buenos Aires 10
Manchester 10
Amman 9
Baghdad 9
Baku 9
Belo Horizonte 9
Jiaxing 9
Lahore 9
Torre del Greco 9
Augusta 8
Boardman 8
Kronberg 8
Las Vegas 8
Pune 8
San Giuseppe Vesuviano 8
Santiago 8
Thái Bình 8
Totale 7.194
Salva come PNG Salva come JPEG
Nome #
Akap1 Regulates Vascular Function and Endothelial Cells Behavior 184
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial 176
Dermcidin: a skeletal muscle myokine modulating cardiomyocyte survival and infarct size after coronary artery ligation 167
Loss of Akap1 exacerbates pressure overload-induced cardiac hypertrophy and heart failure 160
Adverse Post-Ischemic Cardiac Remodeling in Chronic Hindlimb Ischemia: Proteomic Identification of a Novel Molecular Mechanism 155
Infectious endocarditis after transcatheter aortic valve implantation in a patient on oral therapy with glucocorticoids 152
Management of Intraventricular Gradient in Patients With Aortic Stenosis 148
Ankle/brachial index to everyone. 148
Effects of Successful Percutaneous Lower Extremity Revascularization on Cardiovascular Outcome in Patients with Peripheral Arterial Disease 147
A Comparison Between Radial Artery Compression Devices for Patent Hemostasis After Transradial Percutaneous Interventions 145
Renal sympathetic-nerve ablation for uncontrolled hypertension in a patient with single-kidney autosomal dominant polycystic kidney disease. 145
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial 143
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry 143
ADDED Index or percentage diameter of residual coronary stenosis to risk-stratify patients presenting with STEMI 143
RUOLO DELL’UNCOUPLING PROTEIN 3 IN CONDIZIONI IPOSSICO-ISCHEMICHE 142
Extent of cardiac damage and mortality in patients undergoing transcatheter aortic valve implantation 142
IDENTIFICAZIONE PROTEOMICA DI UN NUOVO FATTORE COINVOLTO NELLA MODULAZIONE MOLECOLARE DEL RIMODELLAMENTO CARDIACO POST-ISCHEMICO NELL'ISCHEMIA CRONICA DEGLI ARTI INFERIORI. 141
Predictors of adherence to composite therapy after acute coronary syndromes 140
Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention 138
Effects of Carvedilol Versus Metoprolol on Platelet Aggregation in Patients With Acute Coronary Syndrome: The PLATE-BLOCK Study 138
Arterial hypertension in aortic valve stenosis: A critical update 136
Echocardiographic Evaluation of Aortic Stenosis: A Comprehensive Review 135
L’IMPIANTO DI STENT NELLE ARTERIE DEGLI ARTI INFERIORI RIDUCE IL RISCHIO CARDIOVASCOLARE IN PAZIENTI CON ATEROSCLEROSI PLURIDISTRETTUALE. 135
Molecular modulation of post-ischemic cardiac remodeling by hindlimb ischemia 135
Changes and prognostic impact of noninvasive myocardial work indices in patients undergoing transcatheter aortic valve implantation 134
Echocardiographic Evaluation after Transcatheter Aortic Valve Implantation: A Comprehensive Review 133
Incidence, predictors, and prognostic impact of temporary left bundle branch block after transcatheter aortic valve replacement 132
Cardioprotective role of Urotensin (UT II)- mediated transactivation of the EGFR. 132
Hemodynamic Performance of Transcatheter Aortic Valves: A Comprehensive Review 131
Impact of COVID-19 pandemic on timing and early clinical outcomes of transcatheter aortic valve implantation 130
Il ruolo del danno ischemico remoto permanente sul rimodellamento ventricolare post-IMA 128
Biological effects of statins in atherosclerosis 128
Is There Still a Role for Invasive Assessment of Aortic Gradient? 127
Meta-Analysis of Mortality Outcomes and Mitral Regurgitation Evolution in 4,839 Patients Having Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis. 127
Novel Molecular Approaches in Heart Failure: Seven Trans-Membrane Receptors Signaling in the Heart and Circulating Blood Leukocytes 127
Induction of mitogen activated protein kinases in response to pressure overload: a novel possible biomarker for uncontrolled human hypertension. 126
Effects of Guiding Catheter Disengagement on Resting Indexes for the Assessment of Coronary Artery Stenoses 125
Il ruolo del danno ischemico remoto permanente sul rimodellamento ventricolare post-IMA 125
Il secondo messaggero cAMP e la regolazione della funzione cardiaca: ruolo dell'adenilato ciclasi. 125
Myocardial mass affects diagnostic performance of non-hyperemic pressure-derived indexes in the assessment of coronary stenosis 124
Cardiovascular effects of treadmill exercise in physiological and pathological preclinical settings. 124
CT Coronary Angiography: Technical Approach and Atherosclerotic Plaque Characterization 123
ATHERECTOMY AS ALTERNATIVE ENDOVASCULAR THERAPY FOR INFRAINGUINAL ARTERY DISEASE. 123
Cangrelor in contemporary patients with ST-segment elevation myocardial infarction pretreated with Ticagrelor: Pharmacodynamic data from the POMPEII study 122
Management of Non-Culprit Lesions in STEMI Patients with Multivessel Disease 122
Circulating miR-29a, Among Other Upregulated microRNAs, is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients with Hypertrophic Cardiomyopathy. 121
Rotational atherectomy for the treatment of isolated femoral artery traumatic lesion: A case report 119
Left ventricular diastolic gradient in hypertrophic cardiomyopathy 118
Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: Prespecified subgroup analysis of the BIOSCIENCE trial 118
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial 118
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation 117
Coronary angioplasty with stenting for acute coronary syndrome in patients with isolated single coronary artery: a report of two cases 117
Evidence Supporting Criteria for Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Intervention 116
Gβγ-dependent transactivation of the epidermal growth factor receptor by the Urotensin-II receptor. 116
Correction to: Acute advanced aortic stenosis 115
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation 115
Contemporary use and results of intra-aortic balloon pump counterpulsation. 115
Effects of pressure unloading on mitogen-activated protein kinases in peripheral blood mononuclear cells of patients undergoing trans-catheter aortic valve implantation. 112
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions 111
Stroke volume index and transvalvular flow rate trajectories in severe aortic stenosis treated with TAVR 110
Myocardial Injury After Transcatheter Aortic Valve Replacement According to VARC-3 Criteria 109
EGFR Trans-activation by Urotensin II Receptor is Mediated by Beta-arrestin Recruitment and Confers Cardioprotection in Pressure Overload-induced Cardiac Hypertrophy. 109
Sex and gender specific pitfalls and challenges in cardiac rehabilitation: a working hypothesis towards better inclusivity in cardiac rehabilitation programmes. 108
De-Activation of Mitogen-Activated Protein Kinases in Peripheral Blood Mononuclear Cells of Patients Undergoing Trans-Catheter Aortic Valve Implantation. 108
The circulating level of FABP3is an indirect biomarker of microRNA-1. 107
A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study 107
Acute advanced aortic stenosis 107
Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: results from a multicenter Italian experience 104
Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis 103
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII Registry 102
Venous Thromboembolism and Cancer: A Comprehensive Review from Pathophysiology to Novel Treatment 102
Angiographic complexity of coronary artery disease according to syntax score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: A substudy of the bioscience trial 100
Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI 99
Mortality after Bleeding versus Myocardial Infarction in Coronary Artery Disease: A Systematic Review and Meta-Analysis 99
Renin-angiotensin system inhibitors reduce cardiovascular mortality in hypertensive patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: insights from the EffecTAVI registry 96
Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure 95
From biodegradable polymers to bioresorbable vascular scaffolds: available evidence in the current era of new-generation DES 95
Bioabsorbable drug-eluting vascular scaffold for the treatment of coronary in-stent restenosis: A two center registry 92
One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients 91
Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients with Acute ST-Segment Elevation Myocardial Infarction: Insights from the 2-Year Follow-Up of the BIOSCIENCE Trial 91
Comparative effectiveness and safety of new-generation versus early-generation drug-eluting stents according to complexity of coronary artery disease: A patient-level pooled analysis of 6,081 patients 86
Endovascular repair for isolated iliac artery aneurysms: case report and review of the current literature. 83
Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection 80
Coronary artery disease and myocardial revascularization in patients undergoing transcatheter aortic valve replacement 79
The Conundrum of Permanent Pacemaker Implantation after Transcatheter Aortic Valve Implantation 79
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent for percutaneous coronary revascularization: 2-year results of the BIOSCIENCE trial 78
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY 77
Use of the dual-antiplatelet therapy score to guide treatment duration after percutaneous coronary intervention 76
Rationale and Design of the PARTHENOPE Trial: A Two-by-Two Factorial Comparison of Polymer-Free vs. Biodegradable-Polymer Drug-Eluting Stents and Personalized vs. Standard Duration of Dual Antiplatelet Therapy in All-Comers Undergoing PCI 75
Double layered stents for carotid angioplasty: A meta-analysis of available clinical data 75
Nuovi concetti nella segnalazione beta-adrenergica: prospettive terapeutiche per lo scompenso cardiaco.. [Novel concepts in beta-adrenergic receptor signaling: therapeutic options for heart failure]. 73
Transcatheter Aortic Valve Replacement for the Treatment of Pure Native Aortic Valve Regurgitation: A Systematic Review 73
Prognostic Relevance of Left Ventricular Myocardial Performance After Transcatheter Aortic Valve Replacement 70
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: The GLOBAL LEADERS Adjudication Sub-StudY (GLASSY) 70
Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes 69
Impact of Sex on 2-Year Clinical Outcomes in Patients Treated With 6-Month or 24-Month Dual-Antiplatelet Therapy Duration: A Pre-Specified Analysis From the PRODIGY Trial 68
La modulazione molecolare del rimodellamento cardiaco post-ischemico nell'ischemia cronica degli arti inferiori. 67
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting 66
Incidence and Prognostic Impact of New-Onset Ischemic Symptoms Following Elective Percutaneous Coronary Intervention in Chronic Coronary Syndromes 66
Personalized or Standard Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention 65
Totale 11.443
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.423
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022461 0 0 2 1 13 9 4 24 74 31 80 223
2022/2023648 99 43 25 27 59 54 11 34 83 157 38 18
2023/2024665 20 94 90 62 35 71 25 66 24 17 94 67
2024/20253.510 153 147 16 36 87 154 391 230 297 369 1.337 293
2025/20267.570 723 579 742 738 1.196 328 820 500 967 516 252 209
2026/2027174 137 37 0 0 0 0 0 0 0 0 0 0
Totale 13.805